Results 31 to 40 of about 20,481 (152)

Colistin Resistance Mechanisms in Human Salmonella enterica Strains Isolated by the National Surveillance Enter-Net Italia (2016–2018)

open access: yes, 2022
Background: A collection of human-epidemiologically unrelated S. enterica strains collected over a 3-year period (2016 to 2018) in Italy by the national surveillance Enter-Net Italia was analysed.
Claudia Lucarelli   +18 more
core   +1 more source

Synergistic Activity of Colistin plus Rifampin against Colistin-Resistant KPC-Producing Klebsiella pneumoniae [PDF]

open access: yes, 2013
Infections caused by carbapenem-resistant KPC-producing Klebsiella pneumoniae are responsible for high rates of mortality and represent a major therapeutic challenge, especially when the isolates are also resistant to colistin.
F. Menichetti   +9 more
core   +3 more sources

The effectiveness and nephrotoxicity of loading dose colistin combined with or without meropenem for the treatment of carbapenem-resistant A. baumannii

open access: yesInternational Journal of Infectious Diseases, 2020
Introduction: Acinetobacter baumannii has emerged as an important nosocomial pathogen worldwide. In Thailand, the incidence and mortality rate of carbapenem-resistant A. baumannii (CRAB) is continuously increasing. This organism is a common pathogen that
Wasan Katip   +2 more
doaj   +1 more source

Influence of different antibiotic groups on the development of mutational resistance to colistin among Klebsiella pneumoniae [PDF]

open access: yesКлиническая микробиология и антимикробная химиотерапия, 2021
Objective. To determine the concentration of colistin, preventing the selection of colistin-resistant mutants of K. pneumoniae, and to evaluate the effect of antibiotics of different groups on the development of mutational resistance to colistin ...
Petrovskaya T.A., Tapalskiy D.V.
doaj   +1 more source

Treatment outcome and adverse effects of colistin in adult patients with carbapenem-resistant gram-negative bacteremia from Pakistan

open access: yesInternational Journal of Infectious Diseases, 2021
Background: Polymyxins (colistin) have emerged for the treatment of carbapenem resistant (CR) gram-negative infections. There is a paucity of data on treatment outcomes and adverse effects of high-dose colistin treatment in Pakistan.
Zaheer Udin Babar   +2 more
doaj   +1 more source

Colistin-stimulated ROS production is significantly impaired by the presence of colistin resistance-conferring proteins (EptA/MCR-1/ICR-Mo).

open access: yes, 2018
A & B Accumulation of hydrogen peroxide is boosted by colistin stress in E. coli. C & D The presence of plasmid-borne EptA inhibits colistin-induced production of hydrogen peroxide in E. coli.
Swaminath Srinivas (450675)   +7 more
core   +1 more source

Reversible Nephrotoxicity of Colistin: A Case Report

open access: yes, 2019
Both nosocomial and community acquired gram-negative bacterial infections cause serious morbidity and mortality. However, old antibiotics, which have toxic side effects, should be re-used because of the lack of newly developed antibiotics.
Güle Çınar   +2 more
core   +1 more source

Development of colistin resistance via heteroresistance modeling in : A diagnostic study [PDF]

open access: yesPrecision and Future Medicine
Purpose Colistin heteroresistance mediates the failure of antibiotic treatments, is prone to lead to colistin resistance, and has been frequently reported in Klebsiella pneumoniae.
Jungyu Seo, Kwan Soo Ko
doaj   +1 more source

Colistin-Loaded Polydopamine Nanospheres Uniformly Decorated with Silver Nanodots: A Nanohybrid Platform with Improved Antibacterial and Antibiofilm Performance

open access: yes, 2020
Bacterial infections, especially chronic infections caused by bacterial biofilms, have become a worldwide threat to public health. Encouragingly, the synergistic actions of two or more antibacterial drugs have been proven to be effective in treating ...
Huan-Huan Ran (6630830)   +8 more
core   +1 more source

Novel colistin-EDTA combination for successful eradication of colistin-resistant Klebsiella pneumoniae catheter-related biofilm infections

open access: yesScientific Reports, 2021
Development of an effective therapy to overcome colistin resistance in Klebsiella pneumoniae, a common pathogen causing catheter-related biofilm infections in vascular catheters, has become a serious therapeutic challenge that must be addressed urgently.
Aye Mya Sithu Shein   +23 more
doaj   +1 more source

Home - About - Disclaimer - Privacy